Literature DB >> 17436039

Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis.

Charalampos Mermigkis1, Jeffrey Chapman, Joseph Golish, Demetrios Mermigkis, Kumaraswamy Budur, Antony Kopanakis, Vlassis Polychronopoulos, Richard Burgess, Nancy Foldvary-Schaefer.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic and usually fatal lung disease of unknown etiology. The aim of this study was to describe clinical and polysomnographic features of sleep-related breathing disorders (SRBD) and to identify predictors of obstructive sleep apnea (OSA) in IPF patients. Eight hundred fifty-seven patients with IPF were admitted to the Cleveland Clinic from 2001 to 2005. An all-night polysomnogram (PSG) was performed in 18 of them to investigate complaints suggestive of sleep-disordered breathing. OSA was confirmed in 11 of the 18 IPF patients with complaints suggestive of sleep apnea, while the remain 7 patients had a diagnosis of primary snoring or upper airway resistance syndrome (UARS). All patients showed a reduction in sleep efficiency, REM sleep, and slow wave sleep. The apnea-hypopnea index (AHI) was positively correlated with body mass index (p < 0.0001, r = 0.80). The REM AHI and overall AHI were negatively correlated with FEV(1) (p = 0.008, r = -0.59 and p = 0.04, r = -0.49, respectively) and FVC percentages (p = 0.03, r = -0.50 and p = 0.08, r = -0.42, respectively). Our study is the first describing SRBD in IPF patients. An increased BMI and a significant impairment in pulmonary function testing may be predictors of OSA in this population. In the absence of effective treatments for IPF, the diagnosis and treatment of comorbid SRBD may lead to improvements in quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 17436039     DOI: 10.1007/s00408-007-9004-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   3.777


  29 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Upper airway resistance syndrome is not a distinct syndrome.

Authors:  N J Douglas
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 3.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

4.  Role of snoring and daytime sleepiness in occupational accidents.

Authors:  E Lindberg; N Carter; T Gislason; C Janson
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

5.  A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis.

Authors:  M Clark; B Cooper; S Singh; M Cooper; A Carr; R Hubbard
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

6.  Sleep apnea in sarcoidosis.

Authors:  G A Turner; E E Lower; B C Corser; K L Gunther; R P Baughman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1997-03       Impact factor: 0.670

7.  Upper airway collapsibility during sleep in upper airway resistance syndrome.

Authors:  Avram R Gold; Carole L Marcus; Francis Dipalo; Morris S Gold
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

8.  Recording and scoring leg movements. The Atlas Task Force.

Authors: 
Journal:  Sleep       Date:  1993-12       Impact factor: 5.849

9.  Breathing during sleep in patients with interstitial lung disease.

Authors:  R Perez-Padilla; P West; M Lertzman; M H Kryger
Journal:  Am Rev Respir Dis       Date:  1985-08

Review 10.  Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group.

Authors:  A S Walters
Journal:  Mov Disord       Date:  1995-09       Impact factor: 10.338

View more
  32 in total

1.  Commentary on How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al.

Authors:  Karl-Heinz Ruhle
Journal:  Sleep Breath       Date:  2010-03-16       Impact factor: 2.816

2.  Can we predict the survival of idiopathic pulmonary fibrosis patients? Sleep must be re-appreciated.

Authors:  Paschalis Steiropoulos
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

Review 3.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 4.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

5.  Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?

Authors:  Nabil M Al Lawati; Najib T Ayas
Journal:  Lung       Date:  2008-04-22       Impact factor: 2.584

6.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

7.  Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina Antoniou; Georgios Papadogiannis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2014-07-16       Impact factor: 2.816

8.  CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea--therapeutic difficulties and dilemmas.

Authors:  Charalampos Mermigkis; Demetrios Mermigkis; Georgios Varouchakis; Sophia Schiza
Journal:  Sleep Breath       Date:  2011-01-09       Impact factor: 2.816

9.  Obstructive sleep apnea in patients with interstitial lung diseases: past and future.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Sophia E Schiza
Journal:  Sleep Breath       Date:  2013-04-12       Impact factor: 2.816

10.  CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina M Antoniou; Demetrios Mermigkis; Kostas Psathakis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.